MedTrace Logo

AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study

NCT00734487 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 470

Last updated 2025-10-14

No results posted yet for this study

Summary

The purpose of this study is to identify whether changes in age-related macular degeneration (AMD) over time as seen with spectral domain optical coherence tomography (SDOCT) imaging, can be used to predict vision loss and the advancement of AMD in people at moderate to high risk for progression.

Conditions

  • Age Related Macular Degeneration

Sponsors & Collaborators

Principal Investigators

  • Cynthia A Toth, MD · Duke Health

  • Thomas Hwang, MD · Devers Eye Institute

  • Baker Hubbard, MD · Emory University Eye Center

  • Wai T Wong, MD, PhD · National Eye Institute (NEI)

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00734487 on ClinicalTrials.gov